KROS
Price
$13.45
Change
+$0.04 (+0.30%)
Updated
Jul 3 closing price
Capitalization
546.28M
26 days until earnings call
SPRY
Price
$16.52
Change
-$0.23 (-1.37%)
Updated
Jul 3 closing price
Capitalization
1.62B
32 days until earnings call
Interact to see
Advertisement

KROS vs SPRY

Header iconKROS vs SPRY Comparison
Open Charts KROS vs SPRYBanner chart's image
Keros Therapeutics
Price$13.45
Change+$0.04 (+0.30%)
Volume$148.11K
Capitalization546.28M
ARS Pharmaceuticals
Price$16.52
Change-$0.23 (-1.37%)
Volume$881.49K
Capitalization1.62B
KROS vs SPRY Comparison Chart in %
Loading...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KROS vs. SPRY commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KROS is a Hold and SPRY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (KROS: $13.45 vs. SPRY: $16.52)
Brand notoriety: KROS and SPRY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KROS: 22% vs. SPRY: 61%
Market capitalization -- KROS: $546.28M vs. SPRY: $1.62B
KROS [@Biotechnology] is valued at $546.28M. SPRY’s [@Biotechnology] market capitalization is $1.62B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KROS’s FA Score shows that 1 FA rating(s) are green whileSPRY’s FA Score has 0 green FA rating(s).

  • KROS’s FA Score: 1 green, 4 red.
  • SPRY’s FA Score: 0 green, 5 red.
According to our system of comparison, KROS is a better buy in the long-term than SPRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KROS’s TA Score shows that 3 TA indicator(s) are bullish while SPRY’s TA Score has 5 bullish TA indicator(s).

  • KROS’s TA Score: 3 bullish, 6 bearish.
  • SPRY’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SPRY is a better buy in the short-term than KROS.

Price Growth

KROS (@Biotechnology) experienced а -0.44% price change this week, while SPRY (@Biotechnology) price change was -8.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

KROS is expected to report earnings on Jul 31, 2025.

SPRY is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPRY($1.62B) has a higher market cap than KROS($546M). SPRY YTD gains are higher at: 56.588 vs. KROS (-15.035). KROS has higher annual earnings (EBITDA): 14.8M vs. SPRY (-27.07M). KROS has more cash in the bank: 721M vs. SPRY (276M). SPRY has less debt than KROS: SPRY (73K) vs KROS (18.4M). KROS has higher revenues than SPRY: KROS (215M) vs SPRY (97.1M).
KROSSPRYKROS / SPRY
Capitalization546M1.62B34%
EBITDA14.8M-27.07M-55%
Gain YTD-15.03556.588-27%
P/E RatioN/A152.50-
Revenue215M97.1M221%
Total Cash721M276M261%
Total Debt18.4M73K25,205%
TECHNICAL ANALYSIS
Technical Analysis
KROSSPRY
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 9 days ago
84%
Declines
ODDS (%)
Bearish Trend 6 days ago
82%
Bearish Trend 19 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
Aroon
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PBLAX48.560.68
+1.42%
Principal Blue Chip A
FMCEX37.620.24
+0.64%
Fidelity Advisor Stock Selec Mid Cp C
WCMVX18.280.09
+0.49%
WCM Focused International Equity Ins
FBSIX38.870.18
+0.47%
Franklin Mutual U.S. Mid Cap Value R6
IJMSX16.270.06
+0.37%
VY® JPMorgan Mid Cap Value S

KROS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KROS has been loosely correlated with INZY. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if KROS jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KROS
1D Price
Change %
KROS100%
+0.30%
INZY - KROS
43%
Loosely correlated
N/A
DNLI - KROS
39%
Loosely correlated
-1.41%
XNCR - KROS
38%
Loosely correlated
+1.45%
ALT - KROS
38%
Loosely correlated
-2.86%
XERS - KROS
38%
Loosely correlated
+0.42%
More

SPRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRY has been loosely correlated with XOMA. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRY jumps, then XOMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRY
1D Price
Change %
SPRY100%
-1.37%
XOMA - SPRY
38%
Loosely correlated
+3.26%
ANAB - SPRY
36%
Loosely correlated
-0.54%
OCUL - SPRY
35%
Loosely correlated
+1.69%
RCUS - SPRY
35%
Loosely correlated
-1.40%
KROS - SPRY
33%
Loosely correlated
+0.30%
More